Clinical Trials Logo

Metrorrhagia clinical trials

View clinical trials related to Metrorrhagia.

Filter by:

NCT ID: NCT05594186 Completed - Clinical trials for Intermenstrual Bleeding

Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

A study of the effect of three different nonsurgical methods for management of abnormal uterine bleeding caused by cesarean scar niche. The study was conducted at the Obstetrics and Gynaecology department of the Saudi German Hospital in Madinah- Saudi Arabia, during the period between March 2019 to October 2022. The study protocol was in accordance with the Helsinki declaration 1964 and the later amendments. A prospective approval was granted by the human research ethics committee of the hospital and the study participants have signed an informed consent.

NCT ID: NCT05538689 Recruiting - Pelvic Pain Clinical Trials

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

SOUL
Start date: November 20, 2022
Phase: Phase 4
Study type: Interventional

In this project, the proposition is that the use of daily dosed Myfembree ( a combination of relugolix with estradiol and norethindrone acetate), FDA-approved medication to treat heavy menses fibroid-related symptoms, has the potential to delay the recurrence of fibroid symptoms, prolong the improved quality of life and delay the need for re-intervention after uterine sparing surgery versus the routine standard of care.

NCT ID: NCT05406960 Completed - Hysterectomy Clinical Trials

Therapeutic Effect of Herbal Infusion on Menometrorrhagia

HERBALTREAT
Start date: May 10, 2019
Phase: N/A
Study type: Interventional

This is an interventional, non-randomized, controlled, pilot study that explores a new approach to treat, Abnormal uterine bleeding-menometrorrhagia in women, being candidates for hysterectomy, based on tea infusion consumption of a mixture of two plants.

NCT ID: NCT05062551 Recruiting - Clinical trials for Abnormal Uterine Bleeding

Effectiveness of Three Steps Hysteroscopic Repair of Post Caesarean Isthmocele in Patients With Post Menstrual Spotting

Start date: July 16, 2021
Phase: N/A
Study type: Interventional

Isthmocele is one complications of repeat cesarean sections which is considered as a pocket .that accumulate menstrual blood causing post- menstrual spotting Hysteroscopic resection of the edges of the isthmocele is considered the best treatment option available up to date. Aim of the work: Asses the effectiveness of three steps method resection using hysteroscopy of an isthmocele in patients complained of post -menstrual bleeding with confirmed presence of isthmocele. .

NCT ID: NCT04872244 Completed - Pelvic Pain Clinical Trials

Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele

Start date: November 3, 2019
Phase: N/A
Study type: Interventional

it was planned to investigate the treatment effect of levonorgestrel releasing intrauterine device in patient with isthmocele who were suffering from postmenstrual spotting bleeding and who had no desire for fertility.

NCT ID: NCT04676061 Terminated - Contraception Clinical Trials

Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™

Start date: February 11, 2021
Phase: Phase 4
Study type: Interventional

Effects of norethindrone acetate (NTA) in patients with Nexplanon.

NCT ID: NCT04579965 Not yet recruiting - Clinical trials for Dysfunctional Uterine Bleeding

Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Isthmocele is a growing concern as a cause of abnormal uterine bleeding, especially post menstrual bleeding which may be present in up to 82% of these cases (Iannone et al 2019). our trial is a randomized clinical trial in which women will be randomly allocated to either medical treatment by oral contraceptive or to medical treatment by misotac.

NCT ID: NCT04528108 Completed - Clinical trials for Dysfunctional Uterine Bleeding

Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome

Start date: September 2, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct a randomized, single blind, controlled intervention trial to observe the therapeutic effect of kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine periodic therapy for dysfunctional uterine bleeding based on objective Chinese and western medicine evaluation standard.

NCT ID: NCT04428684 Completed - Clinical trials for Dysfunctional Uterine Bleeding

COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg

Start date: October 29, 2018
Phase: Phase 1
Study type: Interventional

The comparator drug (Zoladex 3.6 mg) is approved for use as a thinning agent for the endometrium prior to endometrial ablation. The dosing recommendation is one or two depots with each depot given four weeks apart. When two depots are administered, surgery should be performed within two to four weeks following administration of the second depot.

NCT ID: NCT04396483 Recruiting - Contraception Clinical Trials

Dysfunctional Uterine Bleeding After Tubal Sterilization

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators will compare the frequency and amount of bleeding after tubal sterilization and salpingectomy